Many patent lawyers will tell you that you never know the value of a patent until it is tested in court.
It actually appears that they realize the value of their patent portfolio as well.
FORBES: The Owner of Yahoo!'s Patents Could Cripple Facebook's IPO Aspirations
If you were counting on the value of the patent portfolio at Research In Motion to bail you out of losses in the stock, maybe you should think again.
FORBES: Research In Motion Patents Worth Just $2.5B, Analyst Says
As a result, the patent system is transferring resources from guys trying to create the next Angry Birds and to patent lawyers who are creating no value.
Providing cutting-edge patent-protected technology at a remarkable value, Trakdot offers innovative solutions that meet global demand.
ENGADGET: Trakdot Luggage hands-on: find your lost bags Hands-on
Pfizer plans to leverage the brand value of Lipitor after the patent expiration.
But Thompson, following Canada's lead, threatened to buy the drug from generic makers, which would have eviscerated the value of Bayer's patent on the drug.
Without the protection of a patent, drugs lose at least 50% of their value in the U.S. to generic competitors.
On March 29th a federal district court in New York made a ruling that, taken at face value, turns America's approach to the patent protection of genes on its head.
And, because the strategic value propositions (or use cases) for a patent often changed as a company developed and competed with others, my approach was an iterative one that was re-visited regularly in case a decision that was appropriate at one time was no longer appropriate because of new information.
FORBES: Old Model: Patents Protect Products. New Model: Patents Themselves Are Products
When the drug goes off patent, that exclusive right vanishes and the drug loses much of its value.
The significance of this patent appears to have been overlooked by investors and our further investigations suggest it has materially greater value than we originally estimated in our initial analysis.
Mervyn Jacobson read about Simons' bumpy journey and was smitten with the idea of finding value in junk DNA. In 1989 they formed GeneType and applied for their first patent covering noncoding regions and HLA. In 2000 GeneType pulled off a reverse merger with a publicly traded Australian shell company that formerly mined for gold.
Claritin will lose patent protection at the end of this year, clearing the way for generics that will zap most of its sales value.
应用推荐